This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Reunion Neuroscience Crecimiento futuro
Future controles de criterios 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Reunion Neuroscience.
Información clave
-14.0%
Tasa de crecimiento de los beneficios
47.3%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 35.7% |
| Tasa de crecimiento de los ingresos | 75.0% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 01 Aug 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 3/31/2026 | N/A | -83 | -87 | -82 | 1 |
| 3/31/2025 | N/A | -71 | -75 | -70 | 2 |
| 3/31/2024 | N/A | -39 | -52 | -47 | 2 |
| 3/31/2023 | N/A | -38 | -28 | -28 | N/A |
| 12/31/2022 | 5 | -74 | -34 | -33 | N/A |
| 9/30/2022 | 5 | -68 | -42 | -40 | N/A |
| 6/30/2022 | 5 | -57 | -46 | -44 | N/A |
| 3/31/2022 | N/A | -18 | -47 | -44 | N/A |
| 12/31/2021 | 1 | -20 | -45 | -42 | N/A |
| 9/30/2021 | 1 | -22 | -36 | -34 | N/A |
| 6/30/2021 | 1 | -24 | -28 | -26 | N/A |
| 3/31/2021 | 1 | -23 | -19 | -17 | N/A |
| 12/31/2020 | 0 | -16 | -12 | -10 | N/A |
| 9/30/2020 | 0 | -9 | -9 | -7 | N/A |
| 6/30/2020 | 0 | -5 | -5 | -4 | N/A |
| 3/31/2020 | 0 | -3 | -3 | -2 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: REUN is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: REUN is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: REUN is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: REUN is forecast to have no revenue next year.
Ingresos de alto crecimiento: REUN is forecast to have no revenue next year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if REUN's Return on Equity is forecast to be high in 3 years time